Viemed Healthcare, Inc. reported significant financial growth in its latest quarterly filing, with total revenue reaching $78.1 million for the three months ended June 30, 2026, marking a 23.9% increase from $63.1 million in the same period last year. For the first half of 2026, revenue totaled $153.5 million, up 25.6% from $122.2 million in the first half of 2025. The company attributed this growth to increased demand for its home medical equipment and services, particularly in the areas of ventilator rentals and women’s health products, as well as contributions from its recent acquisition of Lehan Drugs, Inc.
Despite the revenue increase, net income for the second quarter decreased to $2.9 million, down 10.8% from $3.3 million in the prior year. For the first half of 2026, net income was $5.6 million, a decline of 5.8% compared to $6.0 million in the same period of 2025. The decrease in profitability was primarily due to higher selling, general, and administrative expenses, which rose by 28.9% in the second quarter, reflecting costs associated with the Lehan acquisition and increased staffing to support business growth.
Operationally, Viemed reported a total of 417 licensed respiratory therapists as of June 30, 2026, representing approximately 29% of its total workforce. The company continues to expand its geographic footprint, serving patients in all 50 states, and anticipates further growth through the introduction of new service areas and enhanced clinical offerings. The company’s focus on home-based healthcare aligns with broader industry trends favoring in-home treatment over hospital care, which is expected to drive future demand for its services.
In terms of financial health, Viemed's total assets increased to $204.2 million as of June 30, 2026, compared to $199.2 million at the end of 2025. The company reported cash and cash equivalents of $10.7 million, down from $13.5 million at the end of the previous fiscal year. The company’s debt obligations included $7.4 million under its 2022 Senior Credit Facilities, with no outstanding borrowings under its revolving credit facility. Viemed remains optimistic about its growth trajectory, citing ongoing investments in technology and personnel as key drivers for future performance.
About VIEMED HEALTHCARE, INC.
Viemed Healthcare, Inc. provides home medical equipment and respiratory healthcare services across the U.S., focusing on in-home treatment for respiratory diseases. Its offerings include ventilators, oxygen therapy, sleep testing, and staffing services. Serving primarily Medicare and private insurers, Viemed emphasizes cost-effective, high-quality care, leveraging clinical expertise and technology to support patient health while navigating complex regulatory and reimbursement environments.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.
View the complete official filing on the SEC website.
Read on SEC.gov